136 related articles for article (PubMed ID: 10400646)
1. Protein adducts of iso[4]levuglandin E2, a product of the isoprostane pathway, in oxidized low density lipoprotein.
Salomon RG; Sha W; Brame C; Kaur K; Subbanagounder G; O'Neil J; Hoff HF; Roberts LJ
J Biol Chem; 1999 Jul; 274(29):20271-80. PubMed ID: 10400646
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of low-density lipoproteins produces levuglandin-protein adducts.
Salomon RG; Subbanagounder G; Singh U; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Jul; 10(7):750-9. PubMed ID: 9250408
[TBL] [Abstract][Full Text] [Related]
3. New developments in the isoprostane pathway: identification of novel highly reactive gamma-ketoaldehydes (isolevuglandins) and characterization of their protein adducts.
Roberts LJ; Salomon RG; Morrow JD; Brame CJ
FASEB J; 1999 Jul; 13(10):1157-68. PubMed ID: 10385607
[TBL] [Abstract][Full Text] [Related]
4. Macrophage recognition of LDL modified by levuglandin E2, an oxidation product of arachidonic acid.
Hoppe G; Subbanagounder G; O'Neil J; Salomon RG; Hoff HF
Biochim Biophys Acta; 1997 Jan; 1344(1):1-5. PubMed ID: 9022751
[TBL] [Abstract][Full Text] [Related]
5. Iso[7]LGD2-protein adducts are abundant in vivo and free radical-induced oxidation of an arachidonyl phospholipid generates this D series isolevuglandin in vitro.
Poliakov E; Meer SG; Roy SC; Mesaros C; Salomon RG
Chem Res Toxicol; 2004 May; 17(5):613-22. PubMed ID: 15144218
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing levuglandins produced through the cyclooxygenase and isoprostane pathways.
Salomon RG
Chem Phys Lipids; 2005 Mar; 134(1):1-20. PubMed ID: 15752459
[TBL] [Abstract][Full Text] [Related]
7. Levuglandin E2-protein adducts in human plasma and vasculature.
Salomon RG; Subbanagounder G; O'Neil J; Kaur K; Smith MA; Hoff HF; Perry G; Monnier VM
Chem Res Toxicol; 1997 May; 10(5):536-45. PubMed ID: 9168251
[TBL] [Abstract][Full Text] [Related]
8. Formation and stability of pyrrole adducts in the reaction of levuglandin E2 with proteins.
DiFranco E; Subbanagounder G; Kim S; Murthi K; Taneda S; Monnier VM; Salomon RG
Chem Res Toxicol; 1995; 8(1):61-7. PubMed ID: 7703368
[TBL] [Abstract][Full Text] [Related]
9. Isolevuglandins, a novel class of isoprostenoid derivatives, function as integrated sensors of oxidant stress and are generated by myeloperoxidase in vivo.
Poliakov E; Brennan ML; Macpherson J; Zhang R; Sha W; Narine L; Salomon RG; Hazen SL
FASEB J; 2003 Dec; 17(15):2209-20. PubMed ID: 14656983
[TBL] [Abstract][Full Text] [Related]
10. Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway.
Salomon RG; Batyreva E; Kaur K; Sprecher DL; Schreiber MJ; Crabb JW; Penn MS; DiCorletoe AM; Hazen SL; Podrez EA
Biochim Biophys Acta; 2000 May; 1485(2-3):225-35. PubMed ID: 10832102
[TBL] [Abstract][Full Text] [Related]
11. Levuglandins and isolevuglandins: stealthy toxins of oxidative injury.
Salomon RG
Antioxid Redox Signal; 2005; 7(1-2):185-201. PubMed ID: 15650407
[TBL] [Abstract][Full Text] [Related]
12. Identification of extremely reactive gamma-ketoaldehydes (isolevuglandins) as products of the isoprostane pathway and characterization of their lysyl protein adducts.
Brame CJ; Salomon RG; Morrow JD; Roberts LJ
J Biol Chem; 1999 May; 274(19):13139-46. PubMed ID: 10224068
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the lysyl adducts of prostaglandin H-synthases that are derived from oxygenation of arachidonic acid.
Boutaud O; Brame CJ; Chaurand P; Li J; Rowlinson SW; Crews BC; Ji C; Marnett LJ; Caprioli RM; Roberts LJ; Oates JA
Biochemistry; 2001 Jun; 40(23):6948-55. PubMed ID: 11389610
[TBL] [Abstract][Full Text] [Related]
14. Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D
Cheng YS; Yu W; Xu Y; Salomon RG
J Nat Prod; 2017 Feb; 80(2):488-498. PubMed ID: 28195470
[TBL] [Abstract][Full Text] [Related]
15. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins.
Kaur K; Salomon RG; O'Neil J; Hoff HF
Chem Res Toxicol; 1997 Dec; 10(12):1387-96. PubMed ID: 9437530
[TBL] [Abstract][Full Text] [Related]
16. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase.
Gao L; Zackert WE; Hasford JJ; Danekis ME; Milne GL; Remmert C; Reese J; Yin H; Tai HH; Dey SK; Porter NA; Morrow JD
J Biol Chem; 2003 Aug; 278(31):28479-89. PubMed ID: 12746435
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin endoperoxides 21. Covalent binding of levuglandin E2 with proteins.
Salomon RG; Jirousek MR; Ghosh S; Sharma RB
Prostaglandins; 1987 Nov; 34(5):643-56. PubMed ID: 3481092
[TBL] [Abstract][Full Text] [Related]
18. Measurement of oxidation in plasma Lp(a) in CAPD patients using a novel ELISA.
Podrez EA; O'Neil J; Salomon RG; Schreiber MJ; Hoff HF
Kidney Int; 1998 Aug; 54(2):637-45. PubMed ID: 9690232
[TBL] [Abstract][Full Text] [Related]
19. Isolevuglandin adducts in disease.
Salomon RG; Bi W
Antioxid Redox Signal; 2015 Jun; 22(18):1703-18. PubMed ID: 25557218
[TBL] [Abstract][Full Text] [Related]
20. Levuglandin E2 crosslinks proteins.
Iyer RS; Ghosh S; Salomon RG
Prostaglandins; 1989 Apr; 37(4):471-80. PubMed ID: 2762557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
